V E Valkhoff

Summary

Affiliation: Erasmus MC
Country: The Netherlands

Publications

  1. doi request reprint Prescription of nonselective NSAIDs, coxibs and gastroprotective agents in the era of rofecoxib withdrawal - a 617,400-patient study
    V E Valkhoff
    Department of Medical Informatics, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Aliment Pharmacol Ther 36:790-9. 2012
  2. doi request reprint Adherence to gastroprotection during cyclooxygenase 2 inhibitor treatment and the risk of upper gastrointestinal tract events: a population-based study
    Vera E Valkhoff
    Erasmus University Medical Centre, Rotterdam, The Netherlands
    Arthritis Rheum 64:2792-802. 2012
  3. doi request reprint Risk factors for gastrointestinal bleeding associated with low-dose aspirin
    Vera E Valkhoff
    Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
    Best Pract Res Clin Gastroenterol 26:125-40. 2012
  4. doi request reprint Time-trends in gastroprotection with nonsteroidal anti-inflammatory drugs (NSAIDs)
    V E Valkhoff
    Department of Gastroenterology and Hepatology, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Aliment Pharmacol Ther 31:1218-28. 2010
  5. doi request reprint Risk of recurrent myocardial infarction with the concomitant use of clopidogrel and proton pump inhibitors
    V E Valkhoff
    Department of Gastroenterology and Hepatology, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Aliment Pharmacol Ther 33:77-88. 2011
  6. pmc Cyclo-oxygenase-2 inhibitors or nonselective NSAIDs plus gastroprotective agents: what to prescribe in daily clinical practice?
    G M C Masclee
    Department of Medical Informatics, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Aliment Pharmacol Ther 38:178-89. 2013

Detail Information

Publications6

  1. doi request reprint Prescription of nonselective NSAIDs, coxibs and gastroprotective agents in the era of rofecoxib withdrawal - a 617,400-patient study
    V E Valkhoff
    Department of Medical Informatics, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Aliment Pharmacol Ther 36:790-9. 2012
    ..Gastroprotective strategies are recommended for nonsteroidal anti-inflammatory drug (NSAID) users at risk of upper gastrointestinal (UGI) complications...
  2. doi request reprint Adherence to gastroprotection during cyclooxygenase 2 inhibitor treatment and the risk of upper gastrointestinal tract events: a population-based study
    Vera E Valkhoff
    Erasmus University Medical Centre, Rotterdam, The Netherlands
    Arthritis Rheum 64:2792-802. 2012
    ..We undertook this study to determine the association between GPA adherence and UGI tract events among patients receiving coxibs...
  3. doi request reprint Risk factors for gastrointestinal bleeding associated with low-dose aspirin
    Vera E Valkhoff
    Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
    Best Pract Res Clin Gastroenterol 26:125-40. 2012
    ..In patients with a history of peptic ulcer disease, Helicobacter pylori infection should be assessed and treated. This review focuses on the evidence for upper gastrointestinal risk factors in aspirin users...
  4. doi request reprint Time-trends in gastroprotection with nonsteroidal anti-inflammatory drugs (NSAIDs)
    V E Valkhoff
    Department of Gastroenterology and Hepatology, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Aliment Pharmacol Ther 31:1218-28. 2010
    ..Preventive strategies are advocated in patients at risk of upper-gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs (NSAIDs)...
  5. doi request reprint Risk of recurrent myocardial infarction with the concomitant use of clopidogrel and proton pump inhibitors
    V E Valkhoff
    Department of Gastroenterology and Hepatology, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Aliment Pharmacol Ther 33:77-88. 2011
    ..The association between myocardial infarction (MI) and co-administration of proton pump inhibitors (PPIs) and clopidogrel remains controversial...
  6. pmc Cyclo-oxygenase-2 inhibitors or nonselective NSAIDs plus gastroprotective agents: what to prescribe in daily clinical practice?
    G M C Masclee
    Department of Medical Informatics, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Aliment Pharmacol Ther 38:178-89. 2013
    ....